Sanofi Genzyme begins Phase III COMET clinical trial of neoGAA to treat Pompe disease in UK

Sanofi Genzyme has begun enrolment and dosed the first UK patient for its pivotal Phase III COMET clinical trial of neoGAA to treat Pompe disease.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news